The STEP 1 trial for weight loss: a step change in treating obesity?
Nat Med
.
2021 Apr;27(4):589-590.
doi: 10.1038/s41591-021-01319-4.
Author
Amanda I Adler
1
Affiliation
1
Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK. amanda.adler@dtu.ox.ac.uk.
PMID:
33859431
DOI:
10.1038/s41591-021-01319-4
No abstract available
Publication types
Comment
MeSH terms
Adult
Glucagon-Like Peptides
Humans
Obesity / therapy
Overweight*
Weight Loss*
Substances
semaglutide
Glucagon-Like Peptides